Brand Name(s): Deponit; Nitrodisc; Nitro-Dur; Minitran;
Transderm-Nitro; Nitro-Bid; Nitroglyn; Nitrong; Nitrocine;
Nitrostat
CAS nº: 55-63-0
(nye troe gli' ser in)
About Nitroglycerin
This new site is dedicated exclusively to nitroglycerin.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or pharma industry professional, you can now find out everything you need to know about nitroglycerin, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total nitroglycerin experience!
Why is this medication prescribed?
Nitroglycerin is used to prevent angina attacks (oral tablets, buccal tablets) and to treat attacks once they have started (sublingual tablets, chewable tablets, spray).
Nitroglycerin is in a class of drugs called nitrates. Nitroglycerin dilates (widens) blood vessels (arteries and veins). When blood vessels are dilated, it is easier for the heart to pump and for blood to flow to the heart.
Latest News
Nitroglycerin Improves Health of Premature Babies
Nitroglycerin is a drug used for patients with chest pain, but new research reveals it may also be...
[more]New findings from Japan and the United Kingdom in the area of imaging described Imaging
Investigators in Japan and the United Kingdom have published new imaging data.
[more]Cellegy Pharmaceuticals (CLGY) Appoints Agis To Distribute Rectogesic(R) In Israel
Huntingdon Valley, Penn. / -FirstCall/ -- Cellegy Pharmaceuticals, Inc. announced today that it has...
[more]FDA Issues Approvable Letter To Cellegy Pharmaceuticals For Cellegesic®
Cellegy Pharmaceuticals, Inc. announced that it received late afternoon on Friday, July 7 a...
[more]Case of the Month: Offshore Innovation
When the phone rang at 12:40 a.m. and woke me up, I didn't realize the significance of the incoming...
[more]